The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Gain Therapeutics, Inc(NASDAQ:GANX) 
Gain Therapeutics, Inc. is a redefining drug discovery company with its proprietary target identification platform. It focuses on identifying and optimizing allosteric binding sites and is unlocking new treatment options for disorders characterized by protein misfolding. The company was founded in 2...
Share this website to your friends
Gain Therapeutics Days Payable Outstanding ttm (DPO)
Gain Therapeutics Days Receivable Outstanding ttm (DSO)
Gain Therapeutics Op Cashflow Per Share ttm
Gain Therapeutics Free Cashflow Per Share ttm
Gain Therapeutics Cash Per Share ttm
Gain Therapeutics P/S ratio ttm
Gain Therapeutics (GAAP) P/E ratio ttm
Gain Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.